Abstract
Reduced attentional preference for faces and symptoms of social anxiety are common in autism spectrum disorders (ASDs). The neuropeptide oxytocin triggers anxiolytic functions and enhances eye gaze, facial emotion recognition and neural correlates of face processing in ASD. Here we investigated whether a single dose of oxytocin increases attention to faces in ASD. As a secondary question, we explored the influence of social anxiety on these effects. We tested for oxytocin’s effects on attention to neutral faces as compared to houses in a sample of 29 autistic individuals and 30 control participants using a dot-probe paradigm with two different presentation times (100 or 500 ms). A single dose of 24 IU oxytocin was administered in a randomized, double-blind placebo-controlled, cross-over design. Under placebo, ASD individuals paid less attention to faces presented for 500 ms than did controls. Oxytocin administration increased the allocation of attention toward faces in ASD to a level observed in controls. Secondary analyses revealed that these oxytocin effects primarily occurred in ASD individuals with high levels of social anxiety who were characterized by attentional avoidance of faces under placebo. Our results confirm a positive influence of intranasal oxytocin on social attention processes in ASD. Further, they suggest that oxytocin may in particular restore the attentional preference for facial information in ASD individuals with high social anxiety. We conclude that oxytocin’s anxiolytic properties may partially account for its positive effects on socio-cognitive functioning in ASD, such as enhanced eye gaze and facial emotion recognition.
Highlights
Autism spectrum disorders (ASDs) are associated with difficulties in understanding facial cues that potentially arise from reduced attraction by social information in association with a disturbed development of neural face processing networks during early infancy.[1,2] For example, autistic children display less attentional orienting but enhanced attentional disengagement from facial cues.[3,4] Within the past few years, the neuropeptide oxytocin has been shown to enhance socio-cognitive functions that are frequently impaired in autism spectrum disorder (ASD)
Our study delivers initial evidence that the neuropeptide oxytocin may enhance visual attention toward face cues in ASD to a level observed in neurotypical controls
These positive effects of oxytocin on social attention seem to primarily occur in ASD individuals characterized by high levels of social anxiety and concomitant attentional avoidance of faces
Summary
Autism spectrum disorders (ASDs) are associated with difficulties in understanding facial cues that potentially arise from reduced attraction by social information in association with a disturbed development of neural face processing networks during early infancy.[1,2] For example, autistic children display less attentional orienting but enhanced attentional disengagement from facial cues.[3,4] Within the past few years, the neuropeptide oxytocin has been shown to enhance socio-cognitive functions that are frequently impaired in ASDs.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
